GW Pharmaceuticals – Hot or Not

PUBLISHED: Thu, 07 Sep 2017 05:00:27 GMT

GW Pharmaceuticals (Nasdaq:GWPH) is a UK-based biopharmaceutical company with a cannabinoid product platform. It has a market cap of $2.7 billion, and is not profitable.. Guest Devin Shutte from The Robert Group and resident expert Paul Theron from Vestact decide whether GW Pharmaceuticals is hot or not.